![Thomas Schenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Thomas Schenk served as the Chief Medical Officer at ImpediMed Ltd. from 2022 to 2023.
Prior to this, he obtained undergraduate degrees from Cornell University and Jacobs School of Medicine & Biomedical Sciences.
Anciens postes connus de Thomas Schenk
| Sociétés | Poste | Fin |
|---|---|---|
| IMPEDIMED LIMITED | Directeur Technique/Scientifique/R&D | 26/09/2023 |
Formation de Thomas Schenk
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Jacobs School of Medicine & Biomedical Sciences
 Jacobs School of Medicine & Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
